Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1734221906151165952.png) BiopharmaWatch [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) on x XXX followers
Created: 2025-07-25 15:45:14 UTC

$APLS
Catalyst Date - [2025-07-28]
Drug - EMPAVELI® (pegcetacoplan)
Treatment - [C3 glomerulopathy, primary immune complex membranoproliferative glomerulonephritis]


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948771531662000501/c:line.svg)

**Related Topics**
[c3](/topic/c3)
[$apls](/topic/$apls)

[Post Link](https://x.com/Biopharma_Watch/status/1948771531662000501)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Biopharma_Watch Avatar BiopharmaWatch @Biopharma_Watch on x XXX followers Created: 2025-07-25 15:45:14 UTC

$APLS Catalyst Date - [2025-07-28] Drug - EMPAVELI® (pegcetacoplan) Treatment - [C3 glomerulopathy, primary immune complex membranoproliferative glomerulonephritis]

XXX engagements

Engagements Line Chart

Related Topics c3 $apls

Post Link

post/tweet::1948771531662000501
/post/tweet::1948771531662000501